(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CYLEMBIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CYLEMBIO

ST13

US500000079382512

Class

5

Filing

79382512

Registration

7699741

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

10/04/2025

Trademark type

Word

Nice classes

5

Filing date

09/20/2023

Registration date

02/25/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/25/2025

Last transaction

10/04/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

DK

Examiner

TANNER,MICHAEL R

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

I. A. (pessoa física)

Representatives

Bryce J. Maynard Buchanan Ingersoll & Rooney PC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the prevention and treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricinfection and immune system related diseases; pharmaceutical drugs and pharmaceutical substances for the prevention and treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricinfection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricinfection and immune system related diseases; vaccines

Publications

History of USPTO decisions and trademark events.

36 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/03/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/11/2025

FIMP

FINAL DISPOSITION PROCESSED

09/11/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/25/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

04/19/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/31/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

03/31/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/25/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/25/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/07/2025

PUBO

PUBLISHED FOR OPPOSITION

01/07/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/01/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/11/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/24/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/24/2024

ALIE

ASSIGNED TO LIE

10/24/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

07/17/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/29/2024

GNSL

LETTER OF SUSPENSION E-MAILED

02/29/2024

CNSL

SUSPENSION LETTER WRITTEN

02/29/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

02/29/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/29/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

02/29/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/29/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/31/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/31/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/31/2024

RFNT

REFUSAL PROCESSED BY IB

01/23/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/02/2024

RFRR

REFUSAL PROCESSED BY MPU

01/02/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/21/2023

CNRT

NON-FINAL ACTION WRITTEN

12/20/2023

DOCK

ASSIGNED TO EXAMINER

12/18/2023

MAFR

APPLICATION FILING RECEIPT MAILED

11/10/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/06/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/02/2023

Continuous trademark protection

Get notified about every new filing that threatens CYLEMBIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.